Friday 6 November 2026
Export SY’s income statement to Excel — free account
So-Young International Inc. Sponsored ADR
SY Healthcare Health Information Services
So-Young International Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $217.8 million, up 8.41% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +40.0%
- Free cash flow
- −798.4%
- Total debt
- +99.7%
Quarter to June 2026, against a year earlier
2.06
0.03
−1.44%
Follow SY
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | 7 | 38 | 90 | 165 | 198 | 266 | 182 | 211 | 201 | 218 | 261 | +45.6% | 308 | 419 | 547 | +35.9% | |
| Gross margin, % | 48.68 | 82.72 | 85.17 | 82.75 | 83.61 | 80.63 | 68.73 | 63.66 | 61.30 | 47.77 | 44.43 | (0.9) pt | ||||||
| EBT | (11) | 3 | 8 | 33 | 0 | (3) | (13) | 1 | (81) | (35) | (37) | +13.6% | ||||||
| EBT margin, % | (151.53) | 6.58 | 9.44 | 19.66 | 0.01 | (0.97) | (6.92) | 0.53 | (40.10) | (16.16) | (14.24) | +135.4 pt | ||||||
| Net income | (15) | 0 | 8 | 25 | 1 | (6) | (10) | 4 | (80) | (35) | (35) | +9.6% | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | 0.07 | 0.38 | 2.81 | 2.14 | 3.16 | 2.50 | 1.70 | 2.72 | 1.95 | 2.15 | 2.58 | +45.5% | |||||
| Earnings | (0.20) | (0.02) | (0.22) | 0.24 | 0.01 | (0.01) | (0.09) | 0.03 | (0.78) | (0.34) | (0.34) | +6.1% | ||||||
| Cash flow | (0.06) | 0.13 | 0.91 | 0.71 | 0.44 | 0.12 | (0.15) | 0.04 | (0.03) | (0.15) | 0.00 | +10.4% | ||||||
| Capex | 0.00 | 0.00 | (0.03) | (0.07) | (0.09) | (0.07) | (0.02) | (0.09) | (0.08) | (0.28) | 0.00 | n/m | ||||||
| Free cash flow | (0.06) | 0.13 | 0.88 | 0.64 | 0.35 | 0.06 | (0.17) | (0.05) | (0.12) | (0.43) | 0.00 | +24.1% | ||||||
| Book value | 0.00 | 0.65 | (1.63) | 4.92 | 6.34 | 3.72 | 3.52 | 4.65 | 2.60 | 2.36 | 2.30 | n/m | ||||||
| Shares, m | 100 | 100 | 32 | 77 | 63 | 106 | 107 | 78 | 103 | 101 | 101 | +0.1% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | 0.00 | 0.00 | 455.00 | 58.19 | 787.94 | 0.00 | 0.00 | 41.67 | 0.00 | 0.00 | 0.00 | 134.3 | |||||
| P/S | 0.00 | 0.00 | 0.00 | 5.70 | 3.51 | 1.28 | 0.85 | 0.59 | 0.43 | 1.19 | 0.81 | 1.4 | ||||||
| P/B | 0.00 | 0.00 | 0.00 | 2.48 | 1.75 | 0.86 | 0.41 | 0.35 | 0.32 | 1.09 | 0.91 | 0.7 | ||||||
| EV/Sales | 0.00 | 0.00 | 0.00 | 3.26 | 1.48 | 0.26 | (0.37) | (0.28) | (0.38) | 0.60 | 0.40 | 0.5 | ||||||
| EV/FCF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.66 | (1.13) | (11.17) | 2.68 | (1.68) | (1.34) | (1.1) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | (6) | 13 | 29 | 55 | 27 | 13 | (16) | 3 | (4) | (15) | (32) | +10.5% | |||||
| Capex | 0 | 0 | (1) | (5) | (6) | (7) | (2) | (7) | (9) | (28) | (46) | +81.1% | ||||||
| Free cash flow | (6) | 13 | 28 | 50 | 22 | 6 | (19) | (4) | (12) | (43) | (78) | +24.2% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | 63 | 142 | 358 | 341 | 206 | 200 | 166 | 150 | 100 | 82 | +5.9% | |||||
| Net debt | — | (80) | (176) | (403) | (404) | (269) | (223) | (185) | (162) | (128) | (108) | +6.0% | ||||||
| Shareholders’ equity | — | 66 | (52) | 380 | 398 | 395 | 378 | 361 | 268 | 239 | 232 | +17.5% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | 0.00 | (1.19) | (7.33) | 5.51 | 0.18 | (0.26) | (1.93) | 0.65 | (19.52) | (9.20) | (9.29) | (9.2) pt | |||||
| ROIC | — | 0.00 | 0.00 | 0.00 | 0.00 | (2.53) | (5.99) | (3.05) | (50.34) | (23.16) | (21.77) | (23.2) pt | ||||||
| ROE | 0.00 | 4.31 | 18.40 | 11.09 | 0.23 | (0.33) | (2.46) | 0.81 | (25.68) | (13.67) | (14.44) | (13.7) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | 862 | 1,218 | 1,564 | 2,085 | 1,573 | 1,357 | 1,800 | 2,348 | — | +15.4% | |||||
| Revenue/emp, $m | 0.00 | 0.00 | 0.10 | 0.14 | 0.13 | 0.13 | 0.12 | 0.16 | 0.11 | 0.09 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 2 Nov 2026
So-Young International Inc. Sponsored ADR vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| CTEV Claritev Corporation | $342.7M | — (loss-making) | — (loss-making) | +6.59% (above 0%: growing) | n/m | +49.10% (above 0%: growing) | 73.72% | 9.09% | Compare |
| SPOK Spok Holdings, Inc. | $245.9M | 12.9× | 16.2× | −2.56% (below 0%: shrinking) | +190.31% (above 0%: growing) | +61.57% (above 0%: growing) | 79.66% | 17.08% | Compare |
| AMWL American Well Corporation | $208.5M | — (loss-making) | — (loss-making) | −12.96% (below 0%: shrinking) | n/m | +21.98% (above 0%: growing) | 52.99% | (23.79%) | Compare |
| SY So-Young International Inc. Sponsored ADR | $177.7M | — (loss-making) | 12.8× | +40.84% (above 0%: growing) | n/m | −798.37% (below 0%: shrinking) | 44.11% | (8.64%) | |
| DH Definitive Healthcare Corp. | $163.7M | — (loss-making) | — (loss-making) | −8.99% (below 0%: shrinking) | n/m | −32.60% (below 0%: shrinking) | 77.27% | (9.09%) | Compare |
| OPRX OptimizeRx Corp. | $163.3M | 35.8× | 41.7× | −29.77% (below 0%: shrinking) | n/m | +89.86% (above 0%: growing) | 76.51% | (0.43%) | Compare |
| HCAT Health Catalyst, Inc. | $112.9M | — (loss-making) | — (loss-making) | −26.26% (below 0%: shrinking) | n/m | +65.58% (above 0%: growing) | 42.71% | 89.08% | Compare |
| LFMD LifeMD, Inc. | $110.4M | — (loss-making) | — (loss-making) | −3.55% (below 0%: shrinking) | n/m | −247.52% (below 0%: shrinking) | 88.82% | (15.08%) | Compare |
| CCLD CareCloud, Inc. | $91.8M | 16.5× | 11.0× | +8.56% (above 0%: growing) | +150.00% (above 0%: growing) | −0.44% (below 0%: shrinking) | 50.46% | 19.50% | Compare |
| Median of peers | $163.5M | 16.5× | 16.2× | −6.27% | — | +35.54% | 75.12% | 4.33% |